Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes

Nursing and Health Professions

• Patient 100%
• Incretin 62%
• Combination Therapy 62%
• Inpatient 50%
• Diabetes Mellitus 37%
• Hypoglycemia 37%
• Hospital 25%
• Glucose Blood Level 25%
• Insulin 25%
• Patient with Type 2 Diabetes 25%
• Patient with Diabetes 25%
• Complication 12%
• Morbidity 12%
• Glucose 12%
• Treatment Outcome 12%
• Dipeptidyl Peptidase IV Inhibitor 12%
• Intensive Care 12%
• Hyperglycemia 12%
• Insulin Treatment 12%
• Standard 12%
• Glucagon Like Peptide 1 Receptor Agonist 12%
• Control 12%
• Marker 12%
• Mortality 12%
• Synthesis 12%

Medicine and Dentistry

• Combination Therapy 62%
• Incretin 62%
• Hypoglycemia 37%
• Glycemic Control 25%
• Complication 12%
• Morbidity 12%
• Hyperglycemia 12%
• Glucose 12%
• Diabetes Mellitus 12%
• Intensive Care 12%
• Insulin Release 12%
• Insulin Treatment 12%
• Stress 12%
• Dipeptidyl Peptidase-4 Inhibitor 12%
• Glucagon-Like Peptide-1 Agonist 12%
• Mortality 12%
• Marker 12%
• Therapeutic Procedure 12%

Neuroscience

• Incretin 62%
• Diabetes 50%
• Insulin 37%
• Hypoglycemia 37%
• Glucose 25%
• Hyperglycemia 12%
• Dipeptidyl Peptidase-4 Inhibitor 12%
• Insulin Therapy 12%
• Glucagon-Like Peptide-1 Receptor Agonist 12%